Latest Breaking News On - Tumor markers - Page 2 : comparemela.com

Prostate Cancer Foundation-funded Genetic Study of Men of African Ancestry Finds New Risk Factors for Prostate Cancer

One in six Black men in the United States will be diagnosed with prostate cancer in his lifetime versus one in eight white men.

United statesRobertf smithChristopher haimanCharlesj ryanNational institute on minority healthNational cancer instituteKeck school of medicineHealth disparitiesCancer researchNorris comprehensive cancer centerResearch on prostate cancerProstate cancer foundationGenetic epidemiologyKeck schoolComprehensive cancer centerAfrican american

PROSTATE CANCER FOUNDATION-FUNDED GENETIC STUDY OF MEN OF AFRICAN ANCESTRY FINDS NEW RISK FACTORS FOR PROSTATE CANCER

PROSTATE CANCER FOUNDATION-FUNDED GENETIC STUDY OF MEN OF AFRICAN ANCESTRY FINDS NEW RISK FACTORS FOR PROSTATE CANCER
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRobertf smithChristopher haimanCharlesj ryanNational institute on minority healthNational cancer instituteKeck school of medicineProstate cancer foundationthe foundationStacil vernickprostate cancer foundationHealth disparitiesCancer researchNorris comprehensive cancer centerResearch on prostate cancerProstate cancer foundationGenetic epidemiologyKeck school

The role of autoantibodies biomarkers in precision medicine

This article outlines the powerful role of biomarkers in precision medicine, such as the use of autoantibodies for drug discovery against cancer.

United statesNat genetGama duarteVan normanMaria osipovaClin rheumatolKlunket alVan regenmortelHigh mobility group nucleosome binding domainNational cancer instituteSponsored contentHumoral immuneTestis antigenTestis specific proteiny linkedCancer testis antigenMobility group nucleosome binding domain

New Data Presented at SABCS 2022 Reveal Expanded Predictive Value of the Breast Cancer Index™ Test for Ovarian Function Suppression in Premenopausal Women with HR+ Breast Cancer

The Breast Cancer Index Test Is the First Biomarker to Predict Treatment Benefit in the SOFT Trial . | December 6, 2022

United statesRuth oreganCharlesa deweyAmerican joint committee on cancerAmerican society of clinical oncologyNational comprehensive cancer network incDrug administrationHealth equalityHologic global women health indexEuropean group on tumor markersUniversity of rochesterBiotheranostics incHologic incBreast cancer indexOvarian function trialAntonio breast cancer symposium

Virtual Exams for Routine Surveillance After Ovarian Cancer

Virtual visits may be a suitable alternative to the frequent in-person visits currently mandated for patients who are in remission from ovarian cancer.

New yorkUnited statesJacqueline feinbergInternational journal of gynecologic cancerMemorial sloan kettering cancer centerNew york cityInternational journalOvarian cancerAlignant ovarian neoplasmMalignant lesion of the ovaryAlignant ovarian lesionMalignant ovarian tumorUmor ovary malignantAlignant neoplasiaTumor markersGynecological cancers